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ABSTRACT Key to the virulence of apicomplexan parasites is their ability to move through tissue and to invade and egress from
host cells. Apicomplexanmotility requires the activity of the glideosome, a multicomponent molecular motor composed of a
type XIVmyosin, MyoA. Here we identify a novel glideosome component, essential light chain 2 (ELC2), and functionally char-
acterize the two essential light chains (ELC1 and ELC2) of MyoA in Toxoplasma. We show that these proteins are functionally
redundant but are important for invasion, egress, andmotility. Molecular simulations of the MyoA lever arm identify a role for
Ca2 in promoting intermolecular contacts between the ELCs and the adjacent MLC1 light chain to stabilize this domain. Using
point mutations predicted to ablate either the interaction with Ca2 or the interface between the two light chains, we demon-
strate their contribution to the quality, displacement, and speed of gliding Toxoplasma parasites. Our work therefore delineates
the importance of the MyoA lever arm and highlights a mechanism by which this domain could be stabilized in order to promote
invasion, egress, and gliding motility in apicomplexan parasites.
IMPORTANCE Tissue dissemination and host cell invasion by apicomplexan parasites such as Toxoplasma are pivotal to their
pathogenesis. Central to these processes is gliding motility, which is driven by an actomyosin motor, the MyoA glideosome. Oth-
ers have demonstrated the importance of the MyoA glideosome for parasite motility and virulence in mice. Disruption of its
functionmay therefore have therapeutic potential, and yet a deeper mechanistic understanding of how it works is required.
Ca2-dependent and -independent phosphorylation and the direct binding of Ca2 to the essential light chain have been impli-
cated in the regulation of MyoA activity. Here we identify a second essential light chain of MyoA and demonstrate the impor-
tance of both to Toxoplasmamotility. We also investigate the role of Ca2 and theMyoA regulatory site in parasite motility and
identify a potential mechanism whereby binding of a divalent cation to the essential light chains could stabilize the myosin to
allow productive movement.
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The phylum Apicomplexa comprises a group of obligate intra-cellular parasites, which include medically and agriculturally
important pathogens such as Plasmodium spp., the causative
agents to malaria, Cryptosporidium spp., agents of severe gastro-
intestinal disease, and Toxoplasma gondii, the cause of toxoplas-
mosis. Infection by Plasmodium spp. caused an estimated 198mil-
lion cases of malaria in 2013, resulting in ~564,000 deaths (WHO
World Malaria Report, 2014). Toxoplasma parasites, on the other
hand, are among the most ubiquitous pathogens of humans,
chronically infecting 30% to 80% of populations and causing a
range of medical conditions, including acute tissue damage in
immunocompromised individuals, congenital birth defects af-
flicting ~190,000 births per year (1), and progressive blindness in
some countries.
As with all apicomplexan species, the virulence of Toxoplasma
relies on the ability to perform a unique form of cellular locomo-
tion termed “glidingmotility.” Glidingmotility is used to traverse
host tissue and to invade and, ultimately, egress host cells. It is the
destruction of host tissues endured during this cycle that is the
predominant cause of disease manifestation by apicomplexan
species. Apicomplexan gliding motility is initiated in response to
Ca2 signaling events and is accomplished through the generation
of mechanical force by an actomyosin motor, termed the glideo-
some. The glideosome is a multiprotein complex that resides at
the parasite pellicle, confined to the space between the plasma
membrane (PM) and the inner membrane complex (IMC). The
current model suggests that the glideosome comprises a unique
type XIV myosin, termed MyoA, anchored to a scaffolding com-
plex made up of the glideosome-associated proteins (GAPs) (2–
4). The glideosome is anchored to the IMC by transmembrane
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proteinsGAP40 andGAP50 andmembers of theGAPM family (3,
5, 6), while GAP45 acts as amolecular tether between the IMC and
the PM, maintaining a critical distance between the two mem-
brane systems (3). MyoA then attaches to the GAP complex cour-
tesy of a unique N-terminal extension on its regulatory light chain
(RLC), MLC1 (Plasmodium myosin A tail-interacting protein
[MTIP] homologue) (3, 7, 8). In order tomove with respect to the
host environment, transmembrane adhesins displayed on the sur-
face of parasites are thought to link to the glideosome through
their short cytoplasmic tails. Previous evidence suggested that the
glycolytic enzyme aldolase may act as a bridge between the cyto-
plasmic tails of adhesins and the actin filaments (9, 10) and al-
lowed the proposal of a model that suggested that MyoA activity
and actin treadmilling drag transmembrane adhesins through the
plasma membrane rearward, which in turn drives forward para-
site motion. Recent evidence, however, suggests that aldolase is
likely not an actin-adhensin bridging protein and there may be
some differences between the motor that drives invasion and that
which drives tissue dissemination and that this linear model is an
oversimplification of how the glideosome functions (11–13).
Despite this basic molecular understanding of motility, the
mechanisms that regulate the activity ofMyoA and how this com-
plex generates force remain largely unknown. In other systems,
myosins are usually made up of head, neck, and tail domains. The
head domain hydrolyzes ATP, amplifying small changes in the
active pocket, which leads to a large conformational change in
the converter domain, allowing pivoting against the lever arm.
The myosin lever arm consists of the myosin neck region in asso-
ciation with regulatory light chains (analogous to Toxoplasma
MLC1), essential light chains (ELCs), or calmodulins (CaM). The
lever arm is also often a regulatory site, where direct interactions
with Ca2 or with Ca2-dependent phosphorylation events can
modulatemotor activity (14–18).WhileMyoA has been shown to
be a fast, single-headed plus-end-directed motor (7), little evi-
dence exists on how this unique myosin is activated by the signal-
ing events that are known to regulate motility. MyoA and MLC1
have been shown to be phosphorylated upon activation ofmotility
(19–21), and yet subsequent functional studies demonstrated that
this posttranslational modification has little to no role in its acti-
vation (22, 23). Furthermore, until recently, only a single light
chain—MLC1—was known to exist, thus limiting the possibilities
for investigating motor regulation by the lever arm.
Here we identify a novel essential light chain (ELC2) and de-
scribe the function of this and the previously identified ELC1 of
ToxoplasmaMyoA, thus defining the full lever arm of this impor-
tant molecular motor. We show that ELC1 binds Ca2 and use
structuralmodeling andmolecular dynamics in combinationwith
functional studies to show that key residues predicted to coordi-
nate an interaction interface between ELC1 and MLC1, mediated
by Ca2, can affect the quality, speed, and displacement of para-
sites as they move across a substrate. Our work therefore provides
the first insight into how theMyoA lever arm is stabilized in order
to provide structural rigidity for force generation during the mo-
tility of apicomplexan parasites.
RESULTS
Toxoplasma ELC2 associates with the glideosome. Previously,
we identified a potential essential light chain (ELC1) of the Toxo-
plasma glideosome using quantitative proteomic techniques (19).
Upon further interrogation of the remaining hypothetical pro-
teins detected in the same experiment, we identified a second
calmodulin-like protein (TGME49_305050) with a predicted
mass of 15 kDa, four putative EF hands (EFs) (Ca2 binding re-
gions), and 68%protein sequence similarity to ELC1. The striking
similarities suggested to us that TGME49_305050may be a second
essential light chain (ELC2) and prompted us to investigate its
potential association with the glideosome.
To determine the localization and potential interaction of
ELC2 with the glideosome, we genetically fused a triple-
hemagglutinin (HA3) epitope tag to the C terminus of this protein
at the endogenous locus and performed immunofluorescence and
coimmunoprecipitation (Co-IP)-Western blot analyses of ELC2-
HA-expressing parasites (Fig. 1). Expression of ELC2-HA was
confirmed by Western blotting and compared to expression of
parental (RHHX) and ELC1-HA-expressing parasites (Fig. 1A)
(19). Probing with anti-HA antibodies detected a protein of
~18 kDa in ELC2-HA lysate comparable to ELC1-HA at 17 kDa,
whereas nothing was detected in the parental control (Fig. 1A, left
panel). Antibodies raised to recombinant ELC1 revealed a single
15-kDa protein in parental and ELC2-HA-expressing parasites
but only a higher band (17 kDa), corresponding to the HA-tagged
version of ELC1, in ELC1-HAparasites, thus confirming that anti-
ELC1 antibodies do not cross-react with ELC2 (Fig. 1A, right
panel). Immunofluorescence microscopy of intracellular para-
sites expressing ELC2-HA showed that this protein resides at the
parasite periphery and colocalizes with staining by anti-GAP45
antibodies (Fig. 1B, bottom panel). The localization observed was
very similar to that observed from parasites expressing ELC1-HA
(Fig. 1B, top panel) and was thus consistent with ELC2 being a
component of the glideosome. We then performed Co-IP of
ELC2-HA lysatewith anti-HA to formally establish the interaction
of this protein with various components of the Toxoplasma
glideosome. Upon probing of IP eluates of parental, ELC1-HA
(positive control), and ELC2-HAparasites with antibodies against
the MyoA glideosome, we determined that ELC2 specifically in-
teracts with glideosome components MyoA, GAP45, and MLC1
(Fig. 1C). Interestingly, antibodies to ELC1 did not detect a signal
from the ELC2-HA IP, demonstrating that ELC1 and ELC2
(ELC1/2) do not exist within the same glideosome complexes and
therefore likely compete for the same binding site (Fig. 1C). To
further demonstrate the specificity of the interaction between
ELC2 and the glideosome, we performed a reciprocal IP with anti-
GAP45 antibodies and demonstrated that ELC1-HA and
ELC2-HAwere copurified but that they were not copurified when
normal rabbit (nonspecific) serum (NS) was used (Fig. 1D).
Taken together, these results show that ELC2 is a novel compo-
nent of the Toxoplasma MyoA glideosome which interacts in a
mutually exclusive manner with ELC1.
ELC1 and ELC2 interact with the MyoA neck and, together
with MLC1, define the lever arm. The interaction of an essential
light chain with its myosin heavy chain occurs at themyosin neck.
The complex that they form, together with other regulatory light
chains (analogous to Toxoplasma MLC1) or CaM proteins, de-
fines the myosin lever arm, which forms a stable structure for the
myosin head to pivot against to create force (24). Recently, Book-
walter et al. showed that ELC1 forms a complex with MyoA upon
coexpression using the baculovirus/Sf9 insect cell expression sys-
tem and that this interaction increased the speed at which MyoA
moved actin filaments (25). To specifically determine if ELC1 and
ELC2 interact with the neck of MyoA, we first defined this region
Williams et al.
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tobe the last 61aminoacidsofMyoA(aminoacids770 to831),where
residues 770 to 799 and 800 to 831 contained the putative ELC and
MLC1 binding sites, respectively (Fig. 2A). To investigate this we
generated transgenic versions of the MyoA neck fused to the FKBP-
derived destabilization domain (DD) (26) and anTy epitope tag (27)
for the full neck region (DDTyMyoA770–831) or a truncation lacking
the putative ELC binding region (DDTyMyoA800–831) (Fig. 2B).
These constructs were transiently introduced into MyoA Toxo-
plasma parasites (13) and analyzed for size by Western blotting
with anti-Ty antibodies. The bands were predicted to be ~20 kDa
(DDTyMyoA770-–831) and ~16.5 kDa (DDTyMyoA800–831) but
ran higher (~25 kDa and 20 kDa, respectively), likely due to hy-
drophobicity. The localizations of ELC1, MLC1, and GAP45 were
examined by immunofluorescence microscopy (Fig. 2D). Consis-
tent with our model, and in agreement with previous data (13),
the absence of MyoA had no effect on the targeting of GAP45 or
MLC1 to the pellicle. However, peripheral localization of ELC1
was lost and replacedwith speckled, cytosolic staining, confirming
that MyoA is required to target this CaM-like protein to the par-
asite periphery (Fig. 2D, upper panel). Expression of the full
MyoAneck (DDTyMyoA770–831) rescued the localization of ELC1
(Fig. 2D, middle panel), but expression of a truncatedMyoA neck
lacking the predicted ELC binding site (DDTyMyoA800–831) did
not (Fig. 2D, bottom panel).
To confirm these findings, we then heterologously expressed
ELC1, ELC2, and the MyoA neck region in Escherichia coli and
tested their capacity to interact in vitro by gel filtration chroma-
tography (Fig. 2E). A shift in the retention time was observed for
both ELC1 and ELC2 preincubated with MyoA770–831 compared
to the results seen with the individual components alone (Fig. 2E,
panels i and ii). These results suggest that both ELC1 and ELC2
interact specifically with the MyoA neck, requiring the residues
between 770 and 799 and thus defining the lever arm of theMyoA
glideosome. Furthermore, this also indicates that ELC1 and ELC2
bind to the same region of MyoA.
The IQ motif is a highly basic sequence of approximately
23 amino acids, with a conserved core that usually fits the consen-
sus sequence IQXXXRGXXXR/K. A very degenerate IQ motif is
present downstream from the MLC1 binding site (Fig. 2A). Re-
finement of the structural model presented previously (19) using
molecular dynamics favors interaction of ELC1 with residues 782
to 792 (LVSVLEAYYAG) of MyoA (Fig. 2F). To test this predic-
tion, a full-length His-StrepII-Flag (HSF)-tagged copy of MyoA
(HFS-MyoA) was complemented into MyoA parasites (13) and
3 key hydrophobic residues (L782, L786, and Y790) within the
predicted ELCbinding site weremutated to alanine to createHSF-
MyoA-LLY/AAA (Fig. 2G). Widefield fluorescence microscopy
was performed on MyoA parasites that were complemented
with wild-type HSF-MyoA or mutant HSF-MyoA-LLY/AAA.
While staining with anti-Flag showed peripheral localization for
both wild-type MyoA and mutant MyoA, anti-ELC1 antibodies
detected peripheral staining inwild-type-complemented parasites
FIG 1 ELC2 is a novel component of the MyoA glideosome. (A) Western blot analysis of lysate from ELC2-HA, ELC1-HA, and parental (RHHX) parasites
probed with mouse monoclonal anti-HA antibodies (left panel) and rabbit polyclonal anti-ELC1 antibodies (right panel). (B) Immunofluorescence analysis of
intracellular parasites expressing ELC1-HA and ELC2-HA with anti-HA antibodies (green). The pellicle was detected by costaining with anti-GAP45 antibodies
(red). (C) Immunoprecipitation (IP) of lysate from parental parasites or parasites expressing ELC1-HA or ELC2-HAwithmouse monoclonal anti-HA antibod-
ies. Eluates were analyzed by Western blotting with rabbit anti-HA antibodies (left panel) and with anti-GAP45, anti-MyoA, anti-MLC1 (right panels), and
anti-ELC1 (middle panel). (D) Co-IP of the same lysate as that described for panel C with anti-GAP45 antibodies and nonspecific serum (NS) as a negative
control. Eluates were analyzed by Western blotting with anti-HA antibodies.
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FIG 2 ELC1 and ELC2 interact specifically with the MyoA neck. (A) Amino acid sequence of the MyoA neck region containing two degenerate IQmotifs (core
consensus sequences are underlined). IQmotif 2 is the binding site forMLC1. (B) Schematic representation of transgenicMyoA neck coding sequences fused to
(Continued)
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only and speckled cytosolic staining in mutant-complemented
parasites (Fig. 2H), suggesting that the 3 hydrophobic residues
tested are important for ELC1 binding. Despite several attempts,
parasites stably expressing HSF-MyoA-LLY/AAA could not be
isolated for testing of the functional significance of disrupting this
interaction. It is worth noting that removal ofMyoA or disruption
of the interaction between MyoA and ELC1 led to a speckled
rather than diffuse distribution of ELC1 (Fig. 2D, top and bottom
panels). The possibility cannot be ruled out that disruption of its
interaction with MyoA may cause misfolding of ELC1 and, con-
sequently, mislocalization to inclusion bodies; however, the in
vitro data support the conclusion of the presence of a specific
interaction between the MyoA neck and ELC1.
A single essential light chain (ELC1 or ELC2) is required for
efficient Toxoplasma invasion and egress. To determine the im-
portance of ELC1 and ELC2, conditional knockout (cKO) lines
were generated by replacing the endogenous promoter of ELC1 or
ELC2 with an anhydrotetracycline (ATc)-regulatable promoter in
the Ku80:TATi strain (28, 29) (Fig. 3A, panel i). In addition,
N-terminal triple-HA tags were inserted, creating the cKO-HA3-
ELC1 and cKO-HA3-ELC2 parasite lines (referred to here as cKO-
ELC1 and cKO-ELC2). Regulation of the loci was assayed by
growing parasites for 48 or 96 h in the presence of 1.0 g/ml ATc.
Western blot analysis performed with anti-HA demonstrated the
progressive loss of ELC expression in both cKO-ELC1 and cKO-
ELC2parasites (Fig. 3B). Probingwith anti-ELC1 antibodies dem-
onstrated the absence of cross talk in expression of the two light
chains, and antibodies toToxoplasma catalase were used as a load-
ing control (Fig. 3B). Wide-field fluorescence microscopy of in-
tracellular cKO-ELC1 and cKO-ELC2 parasites following ATc
treatment confirmed the absence of ELC1 and ELC2, respectively
(Fig. 3C).
To assess the function of ELC1 andELC2,we assayed the ability
of mutant parasite lines to invade and egress host cells. Following
growth for 96 h in the presence of ATc, cKO-ELC1 and cKO-ELC2
parasites invaded and egressed normally compared to untreated
and wild-type control parasites (Fig. 3D and E).
To investigate potential functional redundancy of the ELCs, we
next used double-crossover homologous recombination to delete
ELC1 in the cKO-ELC2 line to derive a conditional double-KO
line (cDKO-ELC) (Fig. 3A, panel ii). In contrast to single-cKO
lines, ATc treatment of cDKO-ELC parasites reduced their ability
to invade host cells to 10% of that of the wild type (Fig. 3D).
Furthermore, the capacity of parasites to egress in response to
stimulation for 2.5 min with the Ca2 A23187 ionophore was
severely attenuated (Fig. 3E). ATc-treated cDKO-ELC parasites
were then complemented by transfection with ectopic DDTy-
tagged ELC1 or ELC2. Stabilization of DDTyELC1 or DDTyELC2
with Shld-1 fully restored the invasion and egress capabilities of
the mutant parasites (Fig. 3D and E), thus highlighting that ELC1
and ELC2 are functionally redundant in their roles as the essential
light chain(s) of MyoA during Toxoplasma egress and invasion.
ELC1 and ELC2 are required for the stability of MyoA. As a
first step to determining the function of ELC1 and ELC2 in the
glideosome, we investigated the assembly of the glideosome in
their absence. The data presented in Fig. 2D demonstrate that
MyoA is required for correct localization of ELC1.We then tested
the reciprocal effect of ELCdepletion on the assembly and stability
ofMyoA at the pellicle. To do this,MyoAwasN-terminally tagged
by double homologous recombination with a His-Flag-StrepII
(HFS) tag in cDKO-ELC parasites and the localization of HFS-
MyoA was observed after ELC depletion by ATc. Unexpectedly,
microscopy of intracellular parasites probed with anti-Flag tag
antibodies detected greatly diminished levels of HFS-MyoA after
treatment with ATc (Fig. 4A). In contrast, anti-MLC1 antibodies
stained MLC1 at the periphery of parasites in both the presence
and absence of ELC. Interestingly, a secondary localization of
MLC1 was prominent upon suppression of ELC, where an appar-
ent intracellular structure was marked. This mislocalization is
possibly a cellular response specific to the absence of ELC. Further
investigation byWestern blotting showed that depletion ofMyoA
is concomitant with the depletion of both ELCs but not of either
alone (Fig. 4B), suggesting thatMyoA stability is tightly coupled to
ELC function.
Ca2 interacts with ELC1 and potentially causes an intermo-
lecular interaction between ELC1 and MLC1. To better under-
stand the role of the ELCs in the function of the MyoA lever arm,
in the absence of a crystal structure, we turned to structural mod-
eling. Previously, we presented a homologymodel of the lever arm
complex (MyoAneck-ELC1-MLC1) based on the solved structure
of the scallop myosin II lever arm complex (19). Here, we ex-
tended this model to the complete MyoA protein and performed
molecular dynamics for refinement. The MyoA head has a
nucleotide-binding pocket, so by inclusion of the full-length
MyoA protein wewere able tomodel the complex in various states
of its duty cycle. First, ADP was introduced in the nucleotide-
binding site and Ca2 included at ELC1 EF hand I (EFI), similarly
to that seen with scallop myosin II. The model predicted Ca2 to
be coordinated by the side chains of ELC1 residues D15, D17, and
D19 (Fig. 5A). The binding affinity of Ca2 was estimated by per-
forming pulling simulations of Ca2 from EFI to calculate the
change in free energy (G), which was determined to be 79.0 kJ/
mol (data not shown). Furthermore, ELC1 EFI was predicted to
interact withMLC1 by backbone hydrogen bonds between ELC1-
D17 and MLC1-E179 (Fig. 5A). This interaction between the two
light chains was analyzed by molecular dynamics simulations,
Figure Legend Continued
N-terminal DDTy tags. The full MyoA neck sequence is 61 amino acids in length (residues 770 to 831). Truncation of residues 770 to 799 removed the predicted
ELC binding site. (C) Western blot analysis of mouse monoclonal anti-Ty antibodies and of lysate from RHHX parasites expressing the transgenes shown in
panel B. (D) Immunofluorescence analysis of MyoA parasites transiently expressing DDTyMyoA770-831 and DDTyMyoA800-831. MyoA transgenes were
stabilized by overnight treatment with Shld-1 and detected using mouse anti-Ty antibodies. Localization of glideosome components was detected with rabbit
anti-GAP45, anti-MLC1, and anti-ELC1 antibodies. (E) Size exclusion chromatography of recombinant ELC1, ELC2 (blue), and MyoA neck (black) regions
either separately or together (red). (F) Homology model of the MyoA lever arm predicting that key residues of the MyoA neck (green) interact with ELC1
(orange). (G) Schematic representation of a transgenic version of MyoA. The full MyoA coding sequence was N-terminally fused to His-Flag-StrepII tags, and
three key residues predicted to interact with ELC1 (highlighted in panel F) were mutated to alanine. (H) Immunofluorescence analysis of HFS-MyoA and
HFS-MyoA-LLY/AAA expressed transiently in MyoA parasites (13) by the use of mouse monoclonal anti-Flag tag antibodies. The localization of ELC1 was
examined using anti-ELC1 antibodies. Bars, 5 m.
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FIG 3 Conditional deletion of ELC1 and ELC2 and simultaneous removal of both essential light chains. (A) Schematic representing the genetic methods used
to regulate endogenous essential-light-chain expression. (i) The genetic strategy used to create ELC1 and ELC2 conditional knockouts. The endogenous
promoter of ELC1 and ELC2was replaced with 7 Tet operating sequences and the SAG4minimal promoter (T7S4) inKu80:TATi parasites (29). AHA3 epitope
tag was inserted at the N terminus of ELC1 and ELC2, and transformants were selected for the dhfr gene. In the absence of anhydrotetracycline (ATc), the Tet
transactivator (TATi) drives transcription of ELC1/2. In the presence of ATc, transcription is switched off. (ii) The genetic strategy used to create ELC1 and ELC2
double-knockout parasites. The elc1ORF was replaced with cat to confer chloramphenicol resistance in cKO-ELC2 parasites. (B)Western blot analysis of lysate
fromKu80:TATi, cKO-ELC1, cKO-ELC2, and cDKO-ELC parasites following treatment with 1.0g/ml ATc. Lysates were probed withmouse anti-HA, rabbit
anti-ELC1, and anti-catalase as a loading control. (C) Immunofluorescence analysis of intracellular cKO-ELC1 and cKO-ELC2 parasites grown in the presence
and absence of 1.0g/ml ATc for 96 h. DAPI, 4=,6-diamidino-2-phenylindole. (D) Two-color invasion assay performed on parasites grownwith or without ATc
for 96 h. DDTy-ELC1 and DDTy-ELC2 expression was stabilized by 1.0 M Shld-1 at ~10 h prior to invasion. Numbers of invaded and total parasites were
counted from5 fields per slide. (E) Fixed-egress assay performed on intracellular vacuoles grown for 30 h prior to stimulation with 8 MA23187. More than
100 vacuoles were counted for each slide. In panels D and E, duplicate or triplicate slides were counted per experiment. Column data represent mean percentage
results from 3 independent experiments. Error bars represent SEM.
Williams et al.
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and, interestingly, it was only in simulations when Ca2 was in-
cluded at EFI that a stable interaction formed between the two
light chains, as measured by the distance between the interacting
residues (Fig. 5B; see also Video S1 and Video S2 in the supple-
mental material). The functional redundancy between ELC1 and
ELC2 suggests that key features and residues that contribute to
their role in the MyoA lever arm are likely conserved. To investi-
gate themolecular basis for redundancy,we also generated a struc-
tural model in which ELC1 was replaced with ELC2 (Fig. 5C).
Residues D15 and D19 are conserved between the two essential
light chains (ELC2 residues D16 and D20). The only difference
around the Ca2 binding pocket is found in residue 17/18, which
is an aspartate in ELC1 and an asparagine in ELC2. This does not
imply a large difference regarding the Ca2 binding. The interac-
tion between ELC1/2 and MLC1 is not affected either, as it is
mediated by backbone interactions (Fig. 5A). Furthermore, when
ADP was replaced by ATP at the nucleotide-binding site, a large
conformational change, driven by the bending of the MyoA lever
arm (see Fig. 5D in comparison to 5A [green]), changed the rela-
tive orientations of the two light chains, and both ELC1-R8 and
ELC2-R9 moved into close proximity to the MLC1 backbone
(Fig. 5D).
To test these predictions in vitro, we cloned ELC1 into an E. coli
expression vector and introduced several different mutations to
assess their effect on Ca2 binding. We chose to mutate D15 to
alanine, as this mutation was predicted to ablate Ca2 binding at
EFI (data not shown). To assess the ELC1-MLC1 interaction in the
MyoA-ATP state, we mutated ELC1 R8 to alanine, which was
predicted to disrupt the interaction but not affect Ca2 binding to
EFI. Mutant versions of ELC1 were then expressed and purified
from E. coli in the same manner as with the wild type.
The interaction of ELC1 and Ca2was studied using a thermal
shift assay. Sypro-Orange fluorescent dye emits fluorescence upon
binding hydrophobic regions. Therefore, as the hydrophobic re-
gions of proteins are exposed when the temperature is increased
and the proteins denature, the level of fluorescence emitted also
increases. A thermal denaturation curve is obtained bymeasuring
absorbance over time. Because the thermal stability of a protein
changes uponbinding of an ion such asCa2, this assaywas able to
detect a potential interaction between ELC1 andCa2 by compar-
ing the effects of temperature on absorbance in the presence of
either EGTA or Ca2. We performed thermal shift assays on wild-
type ELC1 and on R8A and D15A mutants in the presence of
either Ca2 or EGTA (Fig. 5E, panels i to iii). As predicted, a shift
in the thermal denaturation curve of ELC1 was seen in the pres-
ence of Ca2 compared to EGTA, indicating that an interaction
occurred (Fig. 5E, panel i). Similarly, a shift between curves when
ELC1-R8A was tested showed that this mutation did not affect
Ca2 binding (Fig. 5E, panel iii). In contrast, little to no change in
the curve was observed for the ELC1-D15A mutant, suggesting
that this mutation was sufficient to disrupt Ca2 binding and
therefore that EFI is likely the only functional Ca2 binding site on
recombinant ELC1 (Fig. 5E, panel ii). We next determined the
affinities of ELC1 and R8A for Ca2 to be 37 (9) M and 43
(10)M, respectively, further suggesting that the R8Amutation
did not affect Ca2 binding (Fig. 5F, panels i and ii).
Molecular dissection of predicted MyoA lever arm interac-
tions during Toxoplasma infectivity.Given our modeling and in
vitro data described above, we hypothesized that Ca2 binding to
ELC1/2 and the subsequent interaction between ELC1/2 and
MLC1 that ourmodeling data predictedwould stabilize theMyoA
lever arm to provide a rigid structure against which the head do-
main could pivot to perform a power stroke for productive Toxo-
plasma invasion, egress, and motility. In order to investigate this
functionally, we created point mutations in either ELC1 orMLC1
and used these to complement conditional KO strains (Fig. 6).We
stably transfected cDKO-ELC parasites with an ectopic version of
wild-type ELC1 (DDTy-ELC1) and mutant form R8A or D15A
FIG 4 Assembly of the MyoA glideosome is disrupted in the absence of two essential light chains. (A) Immunofluorescence analysis of cDKO-ELC parasites
grown with or without ATc. MyoA was detected using anti-Flag in parasites expressing His-Flag-StrepII-MyoA, and the pellicle was marked using anti-GAP45
antibodies. Expression of MLC1 was detected using anti-MLC1 antibodies. Bars, 5 m. (B) Western blot analysis of Ku80:TATi, cKO-ELC1, cKO-ELC2, and
cDKO-ELC parasites grown in the absence or presence of ATc for 7 days and probed with anti-MyoA, anti-HA, and anti-catalase.
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described above (Fig. 6A). Expression of themutant andwild-type
versions of DDTy-ELC1 was evaluated after growing the parasites
in the presence of ATc (as described earlier) and Shld-1 for 10 h
followed by immunofluorescence microscopy. Staining of intra-
cellular parasites with anti-Ty antibodies revealed expression and
peripheral localization of DDTy-ELC1, R8A, and D15A, suggest-
ing that none of the mutations studied affected localization or,
therefore, their association with the glideosome (Fig. 6B).
As a first step to determine the effect of each mutation on
parasite processes, we assessed the ability of intracellular vac-
uoles to egress when stimulated with Ca2 ionophore A23187
for 2.5 min before fixing and examining were performed.While
the expression of wild-type DDTy-ELC1 rescued the egress
block observed for ATc-treated cDKO-ELC parasites, expres-
sion of mutants R8A and D15A restored egress only partially
(Fig. 6C). Similarly, expression of the mutants in ATc-treated
FIG 5 Ca2 binds to ELC1 at EFI, and homology modeling predicts key interactions important for essential-light-chain function. (A) Structural model of
MyoA, ELC1, andMLC1 based on the crystal structures of scallop myosin, with ADP simulated at the nucleotide-binding site of MyoA. A predicted interaction
with Ca2 is shown at EFI, coordinated by the side chains of ELC1 residues. Potential backbone interactions exist between ELC1D17 and the side chain ofMLC1
E179. (B) The interaction between ELC1 andMLC1 is Ca2 dependent. The distances between the interacting residues shown in panel A were measured during
simulations performed in the presence and absence of Ca2. (C) A structural model of MyoA, MLC1, and ELC2 superimposed on the model shown in panel A.
(D) The ATP-bound state of the homology model shown in panel A shows a conformational change of ELC1 EFI. (E) Thermal shift assays on recombinant
wild-type ELC1 (i) andmutant ELC1 (ii and iii) detect interactionswithCa2 by a shift in the temperature of peak fluorescence in the presence of Ca2 compared
to EGTA. (F) The Ca2 dissociation constants (Km) of the recombinant ELC1 proteins shown in panel E standard deviations (SD).
Williams et al.
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FIG 6 Molecular dissection of predicted interactions at theMyoA lever arm. (A) Schematic representation of ectopic versions of ELC1. N-terminal DDTy
tags were fused to the ELC1 coding sequence, and mutations of key residues were introduced. (B) Immunofluorescence microscopy of intracellular
cDKO-ELC parasites stably expressing ectopic wild-type and mutant DDTyELC1 proteins by the use of anti-Ty antibodies (green) and anti-GAP45
antibodies (red). (C and D) Parasites grown with or without 1.0 g/ml ATc for 96 h and with 1.0 M Shld-1 for at least 8 h prior to experiments. (C)
Fixed-egress assay performed on intracellular vacuoles grown for 30 h prior to stimulation with 8 M A23187 for 2.5 min. At least 100 vacuoles were
counted per slide. WT, wild type. (D) Two-color invasion assay performed to determine percentages of invaded parasites after a 30-min infection period.
Numbers of invaded and total parasites were counted from5 fields per slide. (E) Schematic representation of ectopic MLC1. N-terminal DDTy tags were
fused to the MLC1 coding sequence, and mutations of key residues (Fig. 5A) were introduced. (F) Immunofluorescence microscopy of complemented
MLC1 proteins with anti-Ty demonstrates peripheral localization and costaining with glideosome marker anti-GAP45. Bars, 5 m. (G) Egress assay of
MLC1 KO parasites (11) expressing wild-type andmutantMLC1 as shown in panel E. Parasites were treated with 50M rapamycin for 4 h and then grown
without rapamycin for ~96 h prior to egress. DDTyMLC1 proteins were stabilized by 1.0MShld-1 for8 h prior to egress. The experiments represented
in panels C, D, and G used duplicate (C and D) or triplicate (G) slides per experiment. Columns represent mean percentages of the results from 3 to 4
independent experiments. Error bars represent  SEM.
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cDKO-ELC parasites could not fully restore invasion capability
(Fig. 6D).
As we were unable to test the predicted interaction between
ELC1 and MLC1 in the ADP-bound state by mutating ELC1,
given that the interaction involves the ELC1 backbone, we instead
investigated this interaction by mutating MLC1 residues. MLC1-
E179 is predicted to form a hydrogen bond with the ELC1 and
ELC2 backbones (Fig. 5A and C). An earlier iteration of the struc-
turalmodel also predicted an interaction ofMLC1-Y177with ELC
EF1, and yet the refinedmodel shows this residue pointing toward
MLC1 itself. For the purpose of comparison, we mutated both
these residues. To generate a complementation system for MLC1,
we rederived the MLC1 DiCre KO line (loxpMLC1) recently re-
ported (12) and excised themlc1 gene upon addition of rapamycin
(Sigma-Aldrich). We then integrated the wild-type DDTyMLC1
or the Y177A and E179Amutants into the uprt locus of this strain
(Fig. 6E). Expression and localization of the complementing cop-
ies of MLC1 were confirmed by immunofluorescence microscopy
using anti-Ty antibodies. Peripheral staining of Ty was observed
in all lines, and Ty colocalized with anti-GAP45 (Fig. 6F). Next,
loxpMLC1parasites andDDTyMLC1mutant andwild-type com-
plemented parasites were treated with 50 M rapamycin 96 h
prior to egress to induce deletion of endogenous MLC1. Previ-
ously, deletion ofMLC1was reported to cause a complete block of
egress (12). In agreement, we observed egress of only ~3.5% of
rapamycin-treated loxpMLC1 vacuoles compared to untreated or
wild-type controls (Fig. 6G). Expression of DDTyMLC1 fully re-
stored egress capability and expression of DDTyMLC1 mutants
partially restored this ability (Fig. 6G). The greatest defect in egress
was observed when E179 was mutated, resulting in ~72% of the
level of wild-type egress (Fig. 6G). As expected, the phenotypic
defect in egress upon mutation of Y177 (~83% egress) was not as
significant as that seen withmutation of E179 but could have been
due to disrupting its interactions with other hydrophobic resi-
dues, which may affect the rigidity of the MLC1 loop.
Given the major role that MyoA plays during Toxoplasmamo-
tility, we performed an in-depth analysis of parasite movement to
more thoroughly understand the role of the ELC1-MLC1 interac-
tion during pathogenicity. Toxoplasma spp. display three main
types of motility (circular, twirling, and helical) on a two-
dimensional (2D) surface, and live video microscopy was used to
track and quantify these behaviors in the wild-type line (see
Video S3 in the supplemental material) versus the mutant lines
(Fig. 7). Parasites deficient in essential light chains showed only
20% of the gliding frequency of the parental control strain
(Fig. 7A; see also Video S4). Motile cDKO-ELC parasites were
uncoordinated (Video S5) or were limited to a short semicircle of
motion (Video S6). Those that did move traveled a short distance
only (Fig. 7C) and were remarkably slow (Fig. 7D). Parasites ex-
pressing ectopic DDTyELC1 showed reconstitution of the motil-
ity behaviors and parameters measured (Fig. 7; see also Video S7).
Interestingly, however, ELC1 R8A and D15Amutants showed in-
termediary levels of total motile parasites (Fig. 7A), as well as a
greater frequency of uncoordinated motility and twirling move-
ment, but less helical movement, especially in the D15A mutant
(Fig. 7B) (see Video S8 and Video S9, respectively). On average,
those thatmoved glided shorter distances and at lower speeds such
that the R8Amutant showed a greater spread of variability of these
parameters than D15A (Fig. 7C and D).
Recent work has demonstrated that Plasmodium sporozoites
move in a stop-and-go fashion, with periods of rapid movement
followed by periods of slow movement, which are best quantified
by plotting the instantaneous speed versus time (30). We decided
to see if Toxoplasma exhibited the same rhythmic pattern of mo-
tility and could be used as a measure of MyoA lever arm function.
By plotting of the instantaneous velocity of gliding parasites, we
saw that the parental line (Ku80:TATi) displayed oscillating in-
stantaneous speeds, where the velocity reached a maximum of
~5 m/s at a frequency of about 3 rounds per 20 s (Fig. 7E, panel
i). Parasites depleted of both ELCs showedmany fewer oscillations
with a very low maximal velocity (Fig. 7E, panel ii). While com-
plementation with wild-type ELC1 resulted in kinetic parameters
similar to those seen with the parental lines (Fig. 7E, panel iii),
ELC1 R8A showed a lower peak velocity with the same frequency
of bursts of motility (Fig. 7, panel iv). ELC1 D15A showed the
biggest changes in behavior, showing changes inmaximal velocity
aswell as in the frequency ofmotility oscillations (Fig. 7E, panel v).
Overall, our in-depth analysis shows that the coordination of
Ca2 binding by ELC1 and the interaction between the two light
chains of the MyoA lever arm are critical to maintain robust and
frequent motility of Toxoplasma across a 2D surface.
DISCUSSION
Gliding motility is critical to the virulence of apicomplexan para-
sites such as Toxoplasma and Plasmodium spp. (12, 28, 31). Mo-
tility involves the coordinated action of parasite transmembrane
adhesins, actin, actin regulators, and the MyoA-based motor
termed the glideosome, which generates the force required for
motility (32). The experimental tractability of Toxoplasma, to-
gether with advances in genetic techniques, has led to extensive
characterization of the glideosome and its components, and yet
the mechanisms that regulate its activity and, thus, force produc-
tion are still unknown. Motility is initiated in response to intra-
cellular Ca2 signaling events, and reports have shown glideo-
some components MyoA, MLC1, and GAP45 to be
phosphorylated at several sites in a Ca2-dependentmanner (19).
As many conventional myosins, such as scallop and Physarum
myosin II, are regulated by Ca2-dependent phosphorylation of
the regulatory light chain or direct binding of Ca2 to the essential
light chain (14–18), it is possible that the ToxoplasmaMyoA lever
arm (MyoA neck-light chain complex) is similarly a regulatory
site.
We have identified two essential light chains, previously ELC1
(19) and here ELC2, and show that both interact with the MyoA
neck in vitro and in vivo. These essential light chains, together with
MLC1 and the MyoA neck region, define the lever arm (Fig. 8),
and the data have allowed us to investigate the role of this domain
in Toxoplasma gliding motility. In the absence of a structure, we
derived a model of the MyoA-ELC1/2-MLC1 complexes using
homology modeling and molecular dynamic simulations and
identified the region of the MyoA neck where ELC1 and ELC2
bind, and the findings were confirmed by in vivo experiments.
Using the tetracycline conditional-knockout system, we show
that ELC1 and ELC2 have redundant roles in the MyoA glideo-
some but that their shared role is important for all glideosome-
dependent processes. Our results also confirm that ELC1 and
ELC2 interact with MyoA in a mutually exclusive manner and
share the same binding site (Fig. 8), reflecting an emerging theme
of redundancy and plasticity in the apicomplexan invasion and
motilitymachinery. In agreementwith these results, recent studies
Williams et al.
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have demonstrated that at least one additionalmyosin contributes
to Toxoplasmamotility (12, 33). MyoC localizes to the basal com-
plex of tachyzoites, where it also interacts with ELC1 andMLC1 as
well as with GAP proteins and is able to partially compensate for
the loss ofMyoA by relocalizing along the parasite periphery (33).
Furthermore, deletion of the MyoC gene in tachyzoites that lack
MyoA results in greater defects in their ability to glide, invade, and
egress, despite not leading to any impairment when MyoC was
deleted alone (12, 33). As ELC1 is now confirmed to associate with
both MyoA and MyoC (33), it is possible that simultaneous re-
moval of ELC1 and ELC2may in fact disrupt the function of both
myosins, potentially explaining why the deletion of both essential
light chains leads to a more severe defect in some motility-
dependent processes than deletion of MyoA alone (13). The pos-
sibility also remains that either of the two essential light chains
could interact with other Toxoplasma myosins and/or other IQ
motif-containing proteins, as has been shown previously for hu-
man and fly ELCs (34, 35). In the latter case, the conditional re-
moval of endogenous or introduction of mutant essential light
chain presented in this study may also affect unknown cellular
processes. The concept of redundancy and plasticity was also re-
cently established in the invasion pathway for the AMA-RON
pairs (36), and, given the redundancy and plasticity of the ELCs
shown here, together with that discovered for the glideosome
FIG7 Intermolecular interactions at theMyoA lever arm are important forToxoplasma glidingmotility. Tachyzoitemotility assays were performed by live video
microscopy. (A and B) Mean percentages of motile parasites counted for 2 to 3 videos/experiment and for 3 separate experiments. Error bars represent SEM.
(C and D) Mean values were determined by automatic tracking of individual parasites using the MTrackJ plugin for ImageJ. Values were determined from 2 to
3 videos/experiment, where n 3 independent experiments. Error bars represent SEM. (E) Instantaneous speed of representative individual parasites tracked
as described for panels C and D.
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componentsMyoA/C (12, 33) andGAP45/GAP70/GAP80 (3, 33),
it is likely that a greater level of complexity exists to ensure the
production of force for motility in a complex physiological set-
ting. One important difference exists, however, between what we
have found with ELC1 and ELC2 and the redundant mechanisms
in other components as outlined above. Both ELC1 and ELC2
appear to be associated (in a mutually exclusive manner) with the
glideosome under physiological conditions, while other redun-
dant mechanisms have been observed only upon the genetic re-
moval of other components.
Myosin lever arms can be regulated by direct or indirect Ca2-
dependentmechanisms. The direct interaction of ELCs with Ca2
is one suchmethod, and the presence of putative EF hands on both
ELC1 and ELC2 provided the first insight that the essential light
chains may regulate glideosome activity by interacting directly
with Ca2. We compared structural models containing the two
essential light chains and found that, as expected, the Ca2-
binding regions were conserved. Therefore, we performed a de-
tailed investigation of only a single essential light chain, ELC1.We
confirmed that ELC1 has the ability to directly bind Ca2 in vitro
at EFI by using E. coli-expressed wild-type ELC1 in comparison
with an EFI mutant. Furthermore, we then investigated the im-
portance of the residues involved in this interaction in vivo by
assessing the effect of residue mutation on gliding motility, inva-
sion, and egress. In agreement with ourmodel, disruption of a key
residue predicted to coordinate Ca2 activity impaired all gliding-
dependent processes tested. Despite these results, a recent con-
vincing report by Bookwalter et al. showed that the presence of
Ca2 had no effect on the speed of in vitromotility of recombinant
MyoA-ELC1-MLC1 complexes expressed and purified from in-
sect cells (25). A possible explanation for these conflicting results
is provided by the dissociation constant of ELC1 for Ca2 deter-
mined in Fig. 5F. A Ca2 dissociation constant of ~38 M is low,
and if ELC1 can also interactwith other divalent cations, EFI could
instead be occupied by Mg2 (Fig 8), which would be present at a
higher concentration than free Ca2 ions in the cellular environ-
ment. The results of replacement of Ca2 with Mg2 in the struc-
tural model presented here suggest that Mg2 would behave sim-
ilarly to Ca2. Such an interaction has been proven for MlcD, the
light chain of Dictyostelium discoideumMyoD, which has dissoci-
ation constants of 52M for Ca2 and 450M forMg2. In cells,
MlcD interacts withMg2 andmyosin motile activity is regulated
by the concentration of free Mg2 ions (37, 38).
The myosin lever arm is a critical point of rigidity, as the head
domain pivots upon ATP hydrolysis to undertake the power
stroke for force production and subsequent actin displacement
(24, 39–41). In this paper, we present the first in vivo functional
characterization of the ELCs that complete the MyoA lever arm
complex and show their importance for MyoA stability and func-
tion. Our structural modeling suggests a possible mechanism for
lever arm stabilization whereby Ca2 binding to ELC1 or ELC2
could facilitate interactions between the two light chains ELC1/
ELC2 and MLC1, thus rigidifying the lever arm region (Fig. 8). A
similar ELC-regulatory light chain (RLC) interface has been
shown by Ni et al. to be important for nonmuscle myosin II activ-
ity and proposed to be facilitated by phosphorylation of the RLC
(42). We performed a set of functional readouts to test these spe-
cific hypotheses related to key interactions between the different
lever arm components. Ourmutational results confirmed that the
key residues predicted to coordinate these interactions contrib-
uted to MyoA fidelity in vivo, supporting the idea of a role for the
MyoA lever arm in glidingmotility. Likewise, in vitro experiments
by Bookwalter et al. showed that addition of recombinant ELC1 to
a MyoA-MLC1 complex doubled actin filament displacement
velocity in vitro (25), while earlier work demonstrated that
deletion of the last 55 C-terminal residues of MyoA completely
prevented movement of actin filaments with no detrimental
effect on ATPase activity or actin binding capacity shown by
the MyoA head (7).
Our report identifies ELC2 and shows the importance of an
essential light chain to Toxoplasma gliding motility. Furthermore,
it presents an in vivo-validatedmodel of theMyoA lever arm com-
plex, highlighting key residues for lever arm function that are con-
served in ELC1 and ELC2 and offering a mechanistic model for
how the lever arm is stabilized to perform the power stroke to
generate productive motility.
MATERIALS AND METHODS
Cloning of DNA constructs. Refer to Table S1 in the supplemental mate-
rial for all primer information.
Construction of ELC conditional KOs. The ELC1 and ELC2 condi-
tional KO constructs pPR2-3HA-ELC1 and pPR2-3HA-ELC2 were cre-
FIG 8 Model of the ToxoplasmaMyoA glideosome. The composition of the MyoA glideosome in Toxoplasma tachyzoites, localized at the parasite periphery in
the space between the plasma membrane (PM) and inner membrane complex (IMC), is shown.
Williams et al.
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ated by amplifying the 5= flanks of the elc1 and elc2 open reading frame
(ORF) from T. gondii RH strain genomic DNA (gDNA), using primer
pairs 1/2 and 3/4, respectively. The 5= flanks were inserted into the pPR2-
3HA vector with restriction enzymes NdeI and NsiI, and integration was
confirmed by PCR with primer pairs 5/7 and 6/7. Similarly, the elc1 and
elc2 3= flanks were amplified from gDNAwith primer pairs 8/9 and 10/11,
respectively. The 3= flanks were inserted into the vector using XmaI and
NotI restriction sites, and integration was confirmed by PCR with primer
pairs 12/14 and 13/14, respectively. To generate the ELC1 KO construct
pCTY-ELC1 KOLoxP, elc1 5= and 3= flanks were amplified from gDNA
using primer pairs 15/16 and 19/20, respectively, and inserted into the
pTCY-CAT-LoxP vector at restriction sites SpeI and AvrII. Integration of
flanks was confirmed by PCR with primer pairs 17/18 and 21/22, respec-
tively.
Generation of ELC complementing constructs. To generate the ELC
complementation plasmid, an uprt 5= flank was first inserted into the
pCTDDnTy vector (sequence available on request) by digestion with
KpnI. Integration and orientation of the flank were determined by PCR
with primers 23/18 and primers 24/18. The tubulin promoter was then
replaced with the ELC1 promoter by amplifying the elc1 5= flank from
gDNA with primer pair 25/26 and inserting it using SpeI and NdeI. Inte-
gration was confirmed with primers 27/178. The ELC1 and ELC2 coding
sequences were amplified from cDNAwith primer pairs 28/29 and 30/31,
respectively, and inserted at restriction sites XmaI and PstI to create plas-
mids pCUEDDTy-ELC1 and pCUEDDTy-ELC2. To create ELC1 R8A
and D15A mutants, mutagenesis PCR was performed with PfuTurbo Cx
Hotstart DNA polymerase (Agilent Technologies) and pCUEDDTy-
ELC1 with primer pairs 32/33 and 34/35, respectively.
Generation ofMLC1 complementation constructs.TheMLC1 com-
plementation plasmids were created as described above. Briefly, the
MLC1 coding sequence was amplified from cDNA using primer pair
39/40 and inserted into pCUEDDTy. MLC1 mutants Y177A and E179A
were created as described above using primer pairs 41/42 and 43/44, re-
spectively. pCUEDDTy-MLC1-E179A was used as the template for mu-
tagenesis PCR, as described above, with primers 45/46. All plasmids were
confirmed by sequencing and transformed in E. coli BetaDH10 cells.
MyoAneck-ELC interaction constructs.TheToxoplasmaMyoAneck
region (residues 771 to 831) and the truncated MyoA neck missing the
ELC binding site were amplified from cDNAusing primer pairs 36/37 and
38/37, respectively. They were inserted into the pCUEDDTy vector by
digestion with XmaI and PstI to create pCUEDDTy-MyoA neck and
pCUEDDTy-MyoA neck800–831.
E. coli expression constructs.TheToxoplasmaMyoAneck regionwas
amplified from pCUEDDTy-MyoA neck and cloned into the pHUE vec-
tor (55) to give an N-terminal His6-ubiquitin fusion construct (H6Ub-
MyoA-neck). The gene encoding Toxoplasma ELC1 was amplified from
pCUEDDTy-ELC1 and cloned into the pProEXHTb expression vector to
give the pPro-ELC1 expression plasmid. Themutant forms of ELC1 (R8A
and D15A) were amplified from plasmids pCUEDDTy-ELC1-R8A and
-D15A and cloned into pProEX HTb. All plasmids were confirmed by
sequencing and transformed into E. coli BL21(DE3) cells.
Tagging of endogenousMyoAwithHSF.Aconstruct containingHis-
StrepII-Flag (HSF)-tagged MyoA was created using the vector pLIC-
CAT-3HA-LoxP. The MyoA promoter was amplified with primers 50/51
and digested with AflII and AatII. The StrepII-Flag sequence was ampli-
fied from pLIC-SF-TAP using primers 52/53 and a tobacco etch virus
(TEV) sequence inserted 3= with the antisense primer and then digested
with AatII and EcoRV. The MyoA coding sequence was amplified from
cDNA with primers 54/55 and digested with EcoRV and NsiI. The three
products were then inserted into the vector as described above to create
pLIC-CAT-MyoA5=-HSFMyoA-LoxP. An alternative version was created
by replacing the chloramphenicol acetyltransferase (CAT) cassette with
the phleomycin resistance gene BLE to create pLIC-BLE-MyoA5=-
HSFMyoA-LoxP.
Transfection. Tachyzoites were transfected using standard proce-
dures. Freshly lysed parasites were collected at ~107 cells/transfection and
suspended in 400l CytoMix (120mMKCl, 0.15mMCaCl2, 2 nMEGTA,
5 mMMgCl2, 10 mM K2HPO4 and KH2PO4, 25 mM HEPES, pH 7.6) to
which 50 g circular or 20 g linear plasmid DNA was added. The mix
was electroporated at 25 F and 1.5 kV with a Gene Pulser II system
(BioRad) using a 2-mm-gap electrode cuvette (Cell Projects).
Cell culture.Human foreskin fibroblasts (HFFs) (ATCC) were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% (vol/vol) cosmic calf serum (HyClone) at 37°C and 10% CO2.
Toxoplasma tachyzoites were maintained by growth in HFF monolayers
usingDMEMsupplementedwith 1% (vol/vol) fetal bovine serum and 1%
(vol/vol) GlutaMAX (Gibco) at 37°C and 10% CO2.
IFAs. Immunofluorescence assays (IFAs) were performed using stan-
dard procedures. Briefly, intracellular parasites were fixed in 4% parafor-
maldehyde, permeabilized in 0.1%Triton X-100–phosphate-buffered sa-
line (PBS), and blocked in 3% bovine serum albumin (BSA)–PBS.
Specified primary antibodies were diluted in 3% BSA–PBS, decorated
onto blocked slides, and detected with antibodies conjugated to Alexa
Fluor 594 or 488 (Molecular Probes). Parasites were then imaged on a
Zeiss inverted wide-field microscope equipped with AxioCamMRM and
AxioVision (release 4.8) with Deconvolution software.
Coimmunoprecipitation and Western blot analysis. Parasites were
collected promptly after lysis from HFF monolayers and pelleted by cen-
trifugation. All procedures were then performed on ice or at 4°C. Protein
was extracted in IP buffer (20 mM HEPES, 0.15 M NaCl, 1% [vol/vol]
Triton X-100, and 0.5% NP-40 [pH 7.4] with 1 complete protease inhib-
itor cocktail [Roche]), and insoluble material was separated by centrifu-
gation at 55,000 rpm. A 1:100 dilution of the required antibody was added
to 50-l protein G Sepharose and incubated with agitation for 30 min.
Lysate was added to the Sepharose-antibody mix and agitated at 4°C for 1
to 2 h. Immunoprecipitation was performed by centrifugation, and the
reaction mixture was eluted in 2 reducing sample buffer. Eluates were
resolved by SDS-PAGEwith 4% to 12%NuPage bis-Tris gels (Invitrogen)
and run at 150 V (Invitrogen Surelock electrophoresis cell) in MOPS
(morpholinepropanesulfonic acid) running buffer (Invitrogen). Proteins
were transferred from the bis-Tris gels to a nitrocellulose membrane and
then blocked in blocking solution (5% [wt/vol] skim milk powder [De-
vondale]–PBS) for 1 h at room temperature. The desired primary anti-
body was diluted in blocking solution and used to probe membranes for
1 h at room temperature or 4°C overnight. Membranes were incubated in
goat anti-rabbit or anti-mouse horseradish peroxidase (HRP) (Millipore
or Southern Biotech, respectively) diluted in blocking solution for 1 h at
room temperature.Membranes were washed 4 times for 10min each time
in 0.05%human tonicity PBS-Tris (HTPBST) and then immersed in Am-
ersham ECL Western blotting detection reagents (GE Healthcare) for
1 min. Proteins were detected by exposing membranes to Super RXmed-
ical X-ray film (Fuji Film) using a Kodak X-Omat 3000RA processor.
Homology modeling and molecular dynamics. Homology models
were built using the Modeller program (version 9.12) (43) and structures
of scallop myosin as the templates (PDB codes 1KK8 and 3E3R for the
ADP-bound model and PDB code 1B7T for the ATP-bound model).
Molecular dynamics (MD) simulations were carried out using the
GROMACS package (version 4.5.7) (44) and the optimized potential for
liquid simulation/all atom (OPLS/AA) force field (45). Ionizable residues
were assumed to be in their standard state at neutral pH. The complex was
placed in a 115-by-115-by-210-Å (45) TIP4P (46) water box, and water
molecules were replaced by K and Cl ions to neutralize the system and
produce an ionic concentration of 0.1 M. Protein and solvent were cou-
pled separately to a thermal bath at 300 K using a Berendsen thermostat
(47) applied with a coupling time of 0.1 ps; a Berendsen barostat (47) at
1 bar with a coupling time of 0.5 ps was also included. All of the simula-
tions were performed with a single nonbonded cutoff of 10 Å, applying a
neighbor list update frequency of 10 steps (20 fs). The particlemesh Ewald
method (48) was used to account for long-range electrostatics, applying a
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grid width of 1.2 Å and a fourth-order spline interpolation. Bond lengths
were constrained using the LINCS algorithm (49).
All simulations consisted of an initialminimization ofwatermolecules
followed by 200 ps ofMD simulationswith the protein fixed. After remov-
ing all the restraints on the protein, MD simulations were continued for
20 ns. The last 20-ns simulation was analyzed using standard GROMACS
tools.
Ca2-binding free energies were estimated using the GROMACS um-
brella sampling protocol. Starting structures were generated by the use of
a pulling simulation using a force constant of 1,000 kJ/(mol nm2) at a rate
of 1 nm/ns; theCa2 ionwas pulled away from its binding pocket (defined
by the alpha-carbons of the amino acids of the binding loop), and rotation
of the system was prevented using the enforced-rotation function with a
force constant of 500 kJ/(mol nm2). A total of 26 structures were selected
as umbrella sampling windows. They were equilibrated as described
above. A 5-ns simulation was performed in each window for a total sim-
ulation time of 130 ns for umbrella sampling. Analysis of results was
performed with the weighted-histogram analysis method (WHAM) (50).
In vitro protein expression and purification. E. coli BL21(DE3) cells
were grown inTerrific broth containing 100g/ml carbenicillin at 37°C to
an optical density at 600 nm (OD600) of ~0.6, moved at 18°C for 30 min,
and induced with 0.2 mM IP for 16 h. The cells were harvested by centrif-
ugation (7,000 g, 10 min) and stored at80°C until needed. To purify
ELC1 and the R8A and D15A mutants, cell pellets were resuspended in
buffer A (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 10 mM imidazole,
5 mM 2-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride
[PMSF]) and lysed by sonication. Cell debris was removed by centrifuga-
tion at 25,000 g for 30 min and the supernatant applied to a 1-ml bed
volume of nickel-nitrilotriacetic acid (Ni-NTA) agarose resin (Qiagen)
preequilibrated in buffer A. After washing with 5 column volumes of
buffer A was performed, the sample was eluted with buffer supplemented
with 100 mM imidazole. The protein was then loaded onto a size exclu-
sion Superdex 200 10/300-Gl column (GE Healthcare) preequilibrated in
buffer B (50 mM Tris-HCl [pH 7.5] and 250 mM NaCl), and the peak
fractions were pooled, concentrated, and stored at80°C after the addi-
tion of 20% glycerol.
The purification of the H6Ub-MyoA-tail construct was done as fol-
lows. The frozen cell pellet was resuspended in buffer C (50mMTris-HCl
[pH 7.5], 300 mM NaCl, 10 mM imidazole, 10 mM 2-mercaptoethanol,
30% glycerol, and 1 mM PMSF) and lysed by sonication. Unbroken cells
and debris were removed by centrifugation at 25,000 g for 30 min, and
the supernatant was applied to a 1-ml bed volume of Ni-NTA agarose
resin (Qiagen) preequilibrated in buffer C. After washing of the resin with
5 column volumes of buffer C supplemented with 20 mM imidazole was
performed, the protein was eluted in buffer D (50mMTris-HCl [pH 7.5],
150 mM NaCl, 200 mM imidazole, 1 mM 2-mercaptoethanol, and 30%
glycerol). Finally, the protein was loaded onto a size exclusion Superdex
200 columnpreequilibrated in buffer E (10mMHEPES [pH7.4], 150mM
NaCl, 50 MEDTA, and 15% glycerol) and the fractions with the H6Ub-
MyoA-tail protein were pooled, snap frozen in liquid nitrogen, and stored
at80°C until needed.
Thermal shift assay. Binding of Ca2 to ELC1 and its R8A and D15A
mutants was assayed using thermal-shift assays and a Rotor-Gene 3000
real-time PCR machine. The proteins were diluted to a 20 M final con-
centration in buffer F (50 mM Tris-HCl [pH 7.5] and 50 mM NaCl)
containing increasing amounts (108 to 103 M) of CaCl2 in a total reac-
tion volume of 25 l. The fluorescent probe Sypro Orange (Sigma) was
diluted 1:100 in dimethyl sulfoxide (DMSO), and 1 l was added per
sample just before the run. The temperature was raised in 1°C/min steps
from 28°C to 85°C, and fluorescence readings were recorded (excitation,
465 nm; emission, 580 nm). For data analysis, fluorescence was plotted
against temperature, and themelting temperature (Tm) of the sample was
calculated by fitting the sigmoidal melt curve to the Boltzmann equation
as implemented in GraphPad Prism. Data points after the maximum flu-
orescence intensity were excluded from the fitting. The change in Tm as a
function of the logarithm of the Ca2 concentration resulted in a sigmoi-
dal plot, where the half-maximal effective concentration (EC50) was taken
to be equal to the Ca2 affinity (Kd [dissociation constant]). Two ormore
independent titrations were performed for each protein sample.
Egress assay. Parasites were pretreated for 66 h 1.0 g/ml ATc and
then inoculated onto new s and continued to grow for 30 h with or with-
out ATc and/or 1.0 M shield-1. Egress was stimulated by incubating
parasite-infected HFFs with DMEM containing 0.06% DMSO or 8 M
Ca2 ionophore A23187 from Streptomyces chartreusensis (Calbiochem)
for 2.5 min at room temperature before fixation with paraformaldehyde
(PFA) was performed. IFA was performed as described above withmouse
anti-SAG1 antibodies. The average number of ruptured vacuoles was de-
termined by counting a minimum of 100 vacuoles per each slide using
duplicate or triplicate slides for each experiment. Three independent ex-
periments were performed.
Two-color invasion assay. Parasites were grown in HFF cells for 96 h
in the presence and absence of 1.0g/ml ATc and 1.0MShld-1. Freshly
lysed parasites were collected and filtered through a 27-gauge needle to
release the remaining intracellular parasites. Parasites were counted and
adjusted to 2.5 107 cells/ml in warmDMEmediumwith 10mMHEPES
(pH 7.4). The parasite cell suspension was inoculated onto a new conflu-
ent monolayer of HFF cells and grown on glass slides in 24-well plates at
200 l/well in duplicate or triplicate wells. The plate was spun at
1,000 rpm for 1 min to deposit parasites onto the HFF monolayer. Inva-
sion was allowed to proceed for 30 min by incubation at 37°C and 10%
CO2. After incubation, cells were fixed for 10 min in 2.5% PFA–0.06%
glutaraldehyde–HTPBS.A two-color immunofluorescence assaywas then
performed as described previously (51). Extracellular parasites were
probed with anti-SAG1, and all parasites were stained using anti-GAP45
antibodies. Total numbers of parasites and extracellular parasites were
counted for 5 fields of view per slide. Duplicate or triplicate slides were
counted for each experiment. Three independent experiments were per-
formed.
Live gliding-motility assay. Freshly egressed parasites were harvested
and resuspended in warm Endo buffer (44.7 mM K2SO4, 10mMMgSO4,
106 mM sucrose, 5 mM glucose, 20 mM Tris–H2SO4, 3.5 mg/ml BSA,
pH 8.2) and settled onto glass-bottom culture chamber slides (ibidi)
coated with 10 g/ml poly-L lysine–PBS. After the parasites had settled,
Endo buffer was slowly aspirated from the chamber and replaced with
warm gliding buffer (1 mM EGTA, 20 mM HEPES [pH 7.5], DMEM).
Imageswere collected in 2-s intervals for aminimumof 2min. Time-lapse
video microscopy was conducted using a Zeiss Live Scan microscope
equipped with a temperature-controlled chamber tomaintain 37°C incu-
bation. Images were collected using phase contrast under conditions of
low-light illumination and an AxioCam MR camera at 40 magnifica-
tion, using AxioVision release 4.8 software to control the shutters and
camera. Manual tracking of parasites was achieved with the MTrackJ pl-
ugin for ImageJ. Videos were generated using ImageJ software. Motility
analyses were performed as reported previously (52–54).
Statistical analyses.Graphswere prepared and statistical analyses per-
formed using Prism 6 software. All results are presented asmean values
standard errors of themeans (SEM) of the results of at least 3 independent
experiments. Parametric comparisons were tested for statistical signifi-
cance using unpaired, equal variance, two-tailed Student’s t tests. The
Mann-Whitney test was used for nonparametric comparisons.
Accession numbers. The EuPathDB gene accession number for the
ELC2 sequence presented in this paper is TGME49_305050 (previously
TGME49_105050). That for the ELC1 sequence is TGME49_269442 (pre-
viously TGME49_069440).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
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